» Articles » PMID: 17286969

P2X7 Receptor Expression Levels Determine Lethal Effects of a Purine Based Danger Signal in T Lymphocytes

Overview
Journal Cell Immunol
Publisher Elsevier
Date 2007 Feb 9
PMID 17286969
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Contact of T lymphocytes with nicotinamide adenine dinucleotide (NAD) or ATP causes cell death that requires expression of purinergic receptor P2X(7) (P2X(7)R). T cell subsets differ in their responses to NAD and ATP, which awaits a mechanistic explanation. Here, we show that sensitivity to ATP correlates with P2X(7)R expression levels in CD4 cells, CD8 cells and CD4(+)CD25(+) cells from both C57BL/6 and BALB/c mice. But P2X(7)R ligands do not only induce cell death but also shedding of CD62L. It is shown here that in CD62L(high) T cells, CD62L shedding correlates with low expression of P2X(7)Rs and lower cell death, whereas in CD62L(low) cells P2X(7)R expression and death are higher. The possibility is therefore investigated that P2X(7)Rs induce T cell activation. Experiments show that spontaneous T cell proliferation is somewhat higher in cells expressing P2X(7)Rs, but this effect we suggest is caused by P2X(7)R expression on accessory cells.

Citing Articles

CD39 Is Expressed on Functional Effector and Tissue-resident Memory CD8+ T Cells.

Isaacs J, Degefu H, Chen T, Kleist S, Musial S, Ford M J Immunol. 2024; 213(5):588-599.

PMID: 38975728 PMC: 11333163. DOI: 10.4049/jimmunol.2400151.


P2X7 receptor activation impairs antitumour activity of natural killer cells.

Baroja-Mazo A, Penin-Franch A, Lucas-Ruiz F, Torre-Minguela C, Alarcon-Vila C, Hernandez-Caselles T Br J Pharmacol. 2022; 180(1):111-128.

PMID: 36098250 PMC: 10092446. DOI: 10.1111/bph.15951.


P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells.

Vultaggio-Poma V, Di Virgilio F Biomolecules. 2022; 12(7).

PMID: 35883539 PMC: 9313346. DOI: 10.3390/biom12070983.


CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice.

Perez-Lara J, Espinosa E, Santos-Argumedo L, Romero-Ramirez H, Lopez-Herrera G, Garcia-Garcia F Int J Mol Sci. 2021; 22(21).

PMID: 34769406 PMC: 8584421. DOI: 10.3390/ijms222111977.


A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.

Hasan D, Shono A, van Kalken C, van der Spek P, Krenning E, Kotani T Purinergic Signal. 2021; 18(1):13-59.

PMID: 34757513 PMC: 8578920. DOI: 10.1007/s11302-021-09814-6.


References
1.
Baricordi O, Melchiorri L, Adinolfi E, Falzoni S, Chiozzi P, Buell G . Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem. 1999; 274(47):33206-8. DOI: 10.1074/jbc.274.47.33206. View

2.
North R, Surprenant A . Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 2000; 40:563-80. DOI: 10.1146/annurev.pharmtox.40.1.563. View

3.
SOLLE M, Labasi J, Perregaux D, Stam E, Petrushova N, Koller B . Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem. 2000; 276(1):125-32. DOI: 10.1074/jbc.M006781200. View

4.
Mehta V, Hart J, Wewers M . ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem. 2000; 276(6):3820-6. DOI: 10.1074/jbc.M006814200. View

5.
Matzinger P . The danger model: a renewed sense of self. Science. 2002; 296(5566):301-5. DOI: 10.1126/science.1071059. View